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ABSTRACT 
Autism spectrum disorder (ASD) constitutes a group of brain developmental disorders, and it is defined 
by stereotyped behaviour and deficits in communication and social interaction. The prevalence of ASD 
has shown an alarming increase in the recent decades ending up to 1 in 90 children. The exact cause of 
ASD is still not known. Research studies have focused on genetic causes, dysregulation of the immune 
system, inflammation, exposure to environmental toxicants, and the defective gut microbiota. 
Accumulating evidence demonstrates that gastrointestinal symptoms, such as abdominal pain, 
gaseousness, diarrhea, constipation and flatulence, are a common comorbidity in patients with ASD. 
The gut consists of millions of microbiota, and we hypothesize that the microbiota and its metabolites 
might be involved in the pathophysiology of ASD. In Ayurveda all Psycho social abnormalities have 
been included under the category of Unmada. A defective digestive and metabolic function is postulated 
as the root cause of Unmada, leading to systemic accumulation of metabolic wastes (Dhatugataama). 
The metabolic wastes act as systemic toxins and impair the functional integrity of brain. An 
observational study was carried out in the outpatient section of the Department of Kaumarabhrithya, 
Govt. Ayurveda College Hospital for Women and Children, Poojappura, Thiruvananthapuram in 122 
children with ASD. Data pertaining to Socio demographic aspects and clinical manifestations were 
recorded and its prevalence rate was calculated. It was noted that 54% of the cases showed an evident 
disturbance in the digestive mechanism. Constipation was complained by 28% of cases, bloated 
abdomen by 16%, irritable bowel by 8%, increased flatulence by 7% and recurrent diarrhoea by 3%. 
Although these studies did not show a cause-effect relationship between GI symptoms and ASD, the 
findings suggest that the gut plays an important role in the etiology of ASD. Ayurvedic treatment 
strategies that modulate the gut microbiota might constitute a potential therapy for patients with ASD. 
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INTRODUCTION 
 ASD is one among the most enigmatic forms 
of disability mainly due to the socio behavioural 
attributes of the diseased. ASD includes Autism, 
Asperger syndrome, Childhood Disintegrative 
Disorder and Pervasive developmental disorders not 
otherwise specified. It involves severe difficulties in 
basic aspects of social behaviour such as eye contact, 
facial expression, unusual gestures, diminished 
responsiveness, pragmatic deficits, neologism, lack of 
emotions in speech, unusual response to sensory 
stimuli etc. This group of neuropsychiatric disorders 
show specific delay or deviance in social, 
communicative and cognitive development with 
developmental regression, absence of 
protodeclarative pointing, abnormal reaction to 
environmental stimuli, abnormal social interests, 
absence of symbolic play and so on. Global 
prevalence of ASD ranges from 0.07% to 1.8%.[1] A 
population study conducted in nine different centres 
over five zones in India was concluded with a 
prevalence rate of 1.2%.[2] Recent decades have 
witness an alarming increase in prevalence of this 
disorder all over the world. Although the exact cause 
of ASD is still not known, the main findings 
emphasize the role of genetic and environmental 
factors in the development of autistic behaviour.[3] 
Many studies have focused on genetic causes, 
dysregulation of the immune system, inflammation, 
exposure to environmental toxicants, and the gut 
microbiota.[4] Environmental factors are also likely to 
interact with the genetic profile and cause aberrant 
change in brain growth, neuronal development and 
functional connectivity. 
Gut Microbiome 
We coexist with vast populations of microbial 
species that make a host out of the human body. It 
has been estimated that up to 100 trillion microbial 
cells make a home out of us,[5] and likely outnumber 
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human body cells by an order of magnitude[6], leading 
some to term the human microbiome our “second 
genome.”[7] Increasingly, it has become clear that 
these constellations of microbial species are a 
partner in homeostasis, and when the balance is 
tipped away from the healthy microbiome there can 
be a negative outcome on human health.[8] The gut 
consists of millions of microbiota, and we 
hypothesize that the microbiota and its metabolites 
might be involved in the pathophysiology of ASD. 
Several articles have reviewed the influence of the 
gut microbiota on the animal central nervous system 
(CNS) and suggested the existence of a microbiota 
gut-brain axis.[9] The microbiota-gut-brain axis is 
likely the method of communication between the 
brain and the gut microbiota. [10]  
This article reviews the role of the gut 
microbiota in the pathology of ASD. Many studies 
have shown alterations in the composition of the 
fecal flora and metabolic products of the gut 
microbiome in patients with ASD. The gut microbiota 
influences brain development and behaviors through 
the neuroendocrine, neuroimmune and autonomic 
nervous systems. In addition, an abnormal gut 
microbiota is associated with several diseases, such 
as inflammatory bowel disease (IBD), ASD and mood 
disorders. [11] 
Accumulating evidence demonstrates that 
gastrointestinal (GI) symptoms, such as abdominal 
pain, gaseousness, diarrhea, constipation and 
flatulence, are a common comorbidity in patients 
with ASD. The prevalence of GI symptoms ranges 
from 23 to 70% in children with ASD.[12] 
Furthermore, the observed GI symptoms are 
associated with the severity of ASD.[13,14] The gut 
microbiota is directly or indirectly associated with 
ASD symptoms, in part by influencing the immune 
system and metabolism. [15,16] A higher percentage of 
abnormal intestinal permeability was observed in 
36.7% of patients with ASD and their relatives 
(21.2%) compared with control children (4.8%).[17] 
An increased intestinal permeability results in a 
higher antigenic load from the gastrointestinal tract. 
Lymphocytes and ASD-associated cytokines, such as 
interleukin-1β (IL-1β), IL-6, interferon-γ (IFN-γ), and 
tumor necrosis factor-a (TNF-α), are present in the 
circulation and cross the blood-brain barrier (BBB). 
Subsequently, IL-1β and TNF-α bind to brain 
endothelial cells and induce immune responses in the 
brain.[18,19] Immune responses to toxins produced by 
pathogenic microbiota and focal inflammation 
increase gut permeability. 
An impaired intestinal barrier is observed in 
response to infection or stress, which allows the 
translocation of the gut bacteria across the intestinal 
wall and into the mesenteric lymphoid tissue. [20] IgE-
mediated allergic immune response in the intestine 
increases the 5-hydroxytryptamine (5-HT) levels and 
decreases the 5-hydroxyindoleacetic acid (5-HIAA) 
levels in the intestine. It also reduces social 
communication and increases repetitive 
behavior. The pathway via which the microbiota 
communicate with the brain can also involve 
neurotransmitters. The gut microbiota produces 
neuroactive compounds such as dopamine (DA), 5-
HT, γ-aminobutyric acid (GABA) and histamine, 
which activate or inhibit central neurons through the 
vagus nerve[21] Serotonin, which is synthesized in the 
intestines and brain, is important for the regulation 
of mood and cognition.[22] Marler et al., found an 
association between whole-blood serotonin levels 
and GI symptoms in ASD individuals.[23] These 
findings suggest that the gut plays an important role 
in the etiopathology of ASD.  
 Our knowledge of the microbiome has 
excessively expanded over the last few years. For 
example, researchers previously believed that the in 
utero environment was sterile.[24] However, recent 
work has shown that the infant gut is colonized by 
the microbiome of the maternal vagina, anus and skin 
during delivery and by the environmental bacteria to 
which the neonate is exposed during the postpartum 
period.[25] As demonstrated in recent studies, the 
placenta and the amniotic fluid are not sterile.[26] In 
addition, the microbiome in the first meconium of 
mice is not sterile, indicating that the microbiome 
colonizes the infant gut prior to parturition. Maternal 
factors, such as maternal diet and delivery mode, and 
postnatal factors, including antibiotics, breast-
feeding, diet and host genetics, structure the neonatal 
microbiome in humans and animal models.[27] 
 Furthermore, maternal obesity during pregnancy 
and gestational diabetes alter the gut microbiota and 
might be associated with ASD in humans.[28] The birth 
mode and antibiotics also shape the gut 
microbiota.[29] The composition of the microbiota of 
children who were treated with antibiotics during the 
first 3 years of life is less diverse in terms of both 
bacterial species and strains.[30] A population-based 
cohort study revealed the use of various antibiotics 
during pregnancy as a potential risk factor for 
ASD/infantile autism.[31] The early feeding pattern 
also influences the gut microbiota of infants and is 
associated with ASD. Breast-feeding for more than 6 
months is associated with a lower risk of developing 
ASD.[32] Penn et al. studied infants with an older 
sibling diagnosed with ASD and found that breast-
feeding might protect the infants against GI 
symptoms.[33] Infants who were delivered by 
Cesarean section (CS) are at higher risk of developing 
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ASD (odds ratio of 1.23) than infants delivered 
vaginally.[34] Children with ASD have a history of 
using significantly more antibiotics.[35] Thus, early life 
events that can alter the composition of the microbial 
community, such as delivery mode and antibiotic 
exposure, are risk factors for ASD. 
Ayurvedic Perspective 
Ayurvedic classical literature has broadly 
grouped the psycho social anomalies under the 
category of Unmada.[36] In addition to the etiology 
and pathogenesis, the literature vividly elaborates 
the signs, symptoms, and behavioral alterations in 
different psychiatric diseases. The concept of genetic 
defects (Beejadushti) either inherited from the 
parents or due to genetic shuffling and crossover 
during the stages of meiosis and fertilization (swa 
karma klesham) form the platform for all the 
cognitive and behaviour disorders in children.[37] Diet 
and regimen of the lady during pregnancy and mental 
stress has a direct influence in the psychological axis 
of the baby.[38] Auditory impulses experienced during 
that time is given much importance in shaping the 
psychological axis.[39] Gross impairment in above said 
circumstances leads to Alpa Satwa (feeble 
mindedness) of the individual.  
Key role is attributed to the non-congenial 
dietetics (Virudhaahara) in precipitating clinical 
features. Unhygienic diet, intake of putrefied food, 
over eating, food intake in frequent intervals without 
considering the digestive capacity, food preparations 
with incompatible substances, excess use of artificial 
food additives, preservatives and flavonoids can be 
included under the non-congenial dietetics. These 
unhealthy dietetics can easily disturb the digestion 
and metabolism thereby disturbing the gut brain axis 
of the child.[40] Severe systemic illness is also 
attributed to derange the normal Agni and immune 
mechanism thereby making the individual prone to 
develop Psychiatric disorders.[41] Detailed analysis of 
the base somatic features of Unmada reveals that it is 
a disease with an inborn error in the digestive and 
metabolic capacity. Agni, the digestive fire is lacking a 
healthy genetic base in Unmada. So the baby is unable 
to have a proper digestion and metabolism which is 
evident from early infancy. Gut issues like bloated 
abdomen, colics, flatulence, constipation, irritable 
bowel etc are common clinical presentations. These 
digestive errors become more prominent with non-
congenial dietetics. Direct clinical correlation with 
gut issues can be seen with dairy products like milk, 
chocolates, milk sweets, cashew nuts, pista, badam, 
ground nut and white flour. Psychological stress 
plays an important role in regulating the Agni.[42] 
Quality of Agni is influenced by the quantity as well 
as quality of food, compatibility of the food items, 
time and frequency of feeding and the psychological 
disposition of the child at the time of feed.[43-46] Any 
unexpected or unfavourable change in the living 
environment or caretakers is bound to increase the 
stress levels in these kids evident by their 
maladaptation tantrums. Usual accompaniments are 
temper tantrums, reduced span of attention, 
hyperactivity, irritability and disturbed sleep pattern.  
Impaired digestive fire is unable to complete 
the proper digestion, resulting in the undigested or 
semi digested food in the Koshta (intestine) termed 
as Amasanchaya.[47] Among the somatic signs, gut 
dysbiosis - diarrhoea, constipation, bloating etc., goes 
hand in hand with the features of Agnimandyam 
(indigestion) which ends up in Amasancayam 
(accumulation of metabolic wastes) in the body.[48] 
This Agnimandya along with accumulated Ama is 
causing a local inflammation in the gut leading to 
increased permeability of the gut mucosal barrier 
(leaky gut syndrome). The accumulated Ama (semi 
digested or undigested macromolecules) in the 
intestine make its way into the systemic circulation 
and this condition is equated to Dhathugathaama in 
classical literature. [49] Ama entrapped or generated in 
the Dhatus are sure to hamper their functional 
integrity. These etiopathologies which happen in the 
early stages of brain developments has a negative 
impact on its functional maturity and coordinated 
activities. Dhatugathaama gets entrapped in the 
system as it can neither be utilized for bodily 
activities nor expelled as it is cannot find an easy way 
out of the body. So, classical references guide us to 
convert it into simpler molecules (Pachana) and 
couple with fatty preparations (Snehana) to pave its 
way back to Koshta for further elimination.[50]  
Repeated attempts with eliminatory procedures like 
Vamana, Virechana and Vasthi should be made to 
ensure their evacuation. The toxic by-products 
formed from these undigested food can act as toxins 
termed as Amavisha Entrapped Ama may be 
considered as a toxin, antigen or allergen to the body 
and Acharyas have rightly named it as Amavisha. [51] 
Treatment principles of Dooshivisha can also be 
sought of in managing these allergens/ toxins. [52] So, 
Unmada can be considered as a Psychological 
anomaly with a somatic base in the defective Agni. 
 Internal and external oleation (Snehana) 
along with fomentation followed by procedure based 
Panchakarma eliminatory therapies form the corner 
stone in the management of ASD.[53] Healthy mind is 
bound to accompany a healthy body. Correction of 
the Agnimandya with proper medications (Deepana), 
ensuring intake of congenial foods in optimum 
quantity and quality, avoidance of psychological 
stress by Yoga and breathing exercises, proper 
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exercise and play activities will help in improving the 
quality of intestinal microbiome thereby reducing the 
severity of ASD.[54,55] 
Observational Study 
An observational study was carried out in the 
outpatient section of the Department of 
Kaumarabhrithya, Govt. Ayurveda College Hospital 
for Women and Children, Poojappura, 
Thiruvananthapuram in 122 children with ASD. 
Children between 3 to 8 years satisfying the DSM IV 
criteria with a childhood Autism Rating Score above 
30 was included in the study. Socio demographic and 
clinical data related to Agnimandya and GIT 
abnormalities were collected. 
Age distribution of participants 
Table No. 1: Age distribution of participants 
Variable Total 
 Age Number Percentage 
3-4 yrs 28 23% 
4-5 yrs 20 16% 
5-6 yrs 22 18% 
6-7 yrs 15 12% 
7-8 yrs 37 30% 
Total 122 100% 
Fig No. 1: Age distribution of participants 
 
Age wise distribution of the participants showed 23 % of them were from 3 yrs, 16% from 4, 18% from 5 
yrs, 12% from 6 yrs and 30% from 7 yrs. The higher contribution from upper age group point towards the 
necessity of popularizing Ayurvedic treatment among the public to facilitate early intervention. 
Gender wise distribution of participants 
Table No. 2: Gender distribution of participants 
Variable Total 
Gender Number Percentage 
Boys 91 75% 
Girls 31 25% 
Total 122 100% 
Fig No. 2: Gender distribution of participants 
 
Gender wise distribution of the recruited patients depicted that 75% were boys and 25% were girls. Gender 
based data analysis came out with a male to female ratio of 3:1. Our study is in consistent with the meta-
analysis, in spite of the fact that sex ratio of birth in Kerala reports 1:1.064 (M:F) 
 
 
3-4 yrs 4-5 yrs 5-6 yrs 6-7 yrs 7-8 yrs
Boys Girls
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Distribution of participants as per Severity of Autism 
Table No. 3: Severity of Autism in children  
Variable Total 
No. % 
Mild to Moderate 62 51% 
Severe 60 49% 
Total 122 100% 
Fig No. 3: Severity of Autism in children 
 
A case having a CARS2-ST score above 30 was recruited into the study. CARS2-ST score below 36.5 can 
be designated as mild to moderate Autism and above as severe cases. The study could ensure almost equal 
participation from both the groups.  
Distribution of participants as per exclusive Breast feeding time 
Table No. 4: Exclusive Breast feeding time 
Variable Total 
EBF months Number Percentage 
Less than 3 30 25% 
3 to 6 89 73% 
More than 6 3 2% 
Total 122 100% 
Fig No. 4: Exclusive Breast feeding time 
 
 It was observed that 25% of mothers stopped exclusive breast feeding before 3 months. This finding is 
in accordance with the Meta-analysis reports stating that exclusive breast feeding may protect against the risk 
of developing ASD. 
Distribution of participants as per Mode of Delivery 
Table No. 5: Mode of Delivery 
Variable Total 
Mode of Delivery Number Percentage 
Normal vaginal 55 45% 
Assisted 11 9% 
LSCS 56 46% 
Total 122 100% 
 
Mild to Moderate Severe
Less than 3 3 to 6 More than 6
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Fig No. 5: Mode of Delivery 
 
 The world is currently witnessing an increase in the rate of caesarean sections which can be ascribed to 
many factors including socio-economic factors and personal preferences apart from the clinical indications. A 
community based cross sectional study conducted in Kerala has come up with a caesarean section rate of 
37.7%. The rate of LSCS in the present study is much more (46%) than the expected level. This study confirms 
previous findings that children born by LSCS are more likely to be diagnosed as having ASD. However, the 
association did not persist when using sibling controls, implying that this association is due to familial 
confounding by genetic and/or environmental factors. 
Distribution of participants as per eating habits 
Table No. 6: Eating habits in participants 
Variable Total 
Eating habits No. % 
Normal 12 10% 
Picky eater 32 26% 
Over eating 19 16% 
Dry/ Crispy foods 33 27% 
Taste preference 5 4% 
Picky dry 7 6% 
Picky & taste pref. 2 2% 
Dry over eater 7 6% 
Over eater taste pref. 1 1% 
Dry & taste pref 3 2% 
Picky, dry & taste pref 1 1% 
Total 122 100% 
Fig No. 6: Eating habits in participants 
 
Children with autism frequently have significant eating difficulties with highly restricted range of food 
choices. The purpose of this data analysis was to get a parent survey of feeding patterns in children with autism 
to give a new perspective for both parents and professionals. 
Normal vaginal Assisted LSCS
0 5 10 15 20 25 30 35
Normal
Picky eater
Over eating
Dry/ Crispy foods
Taste preference
Picky dry
Picky & taste pref.
Dry over eater
Over eater taste pref.
No.
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 Picky eaters are very selective about what they eat. They are reluctant to eat, or even taste new foods. 
This result in children eating a limited variety of foods and this group comprises of 35%. Certain groups of kids, 
due to their sensory issues, are used to dry foods alone. They usually avoid wet side dishes and are fond of 
crispy food items. 42% of cases were under this group. Over eating was noted in 23%. Certain other group 
(10%) has special preference to particular tastes like sweet/ spicy. 
Distribution of participants as per prevalence of Gut issues 
Table No. 7: Gut issues in participants 
Variable Total 
Gut issues No. % 
Nil 56 46% 
Bloated  14 11% 
Constipated  27 22% 
Irritable bowel  8 7% 
Diarrhoea 4 3% 
Flatulence  4 3% 
Bloated + Constipated 5 4% 
Bloated + Flatulence 1 1% 
Constipated + Flatulence 2 2% 
Irritable bowel + Flatulence 1 1% 
Total 122 100% 
Fig No. 7: Gut issues in participants 
 
Data pertaining to gut issues were collected 
from the informants. It was noted that 54% of the 
cases showed an evident disturbance in the digestive 
mechanism. Bloated abdomen was complained by 
16% of cases, constipation by 28%, irritable bowel by 
8%, increased flatulence by 7% and recurrent 
diarrhoea by 3%. Studies in this field states that, 
compared to normal children, those with ASD were 
more likely to have at least one frequent gastro-
intestinal symptom. This data highlights the 
prevalence of digestive errors in these kids. 
Maladaptive behaviours correlate with gastro-
intestinal problems, suggesting these comorbidities 
require attention.  
 
 
CONCLUSION 
  This study emphasizes the role of defective 
gut microbiome in precipitating the socio 
behavioural problems in ASD kids. At present, there 
are no effective therapies for ASD. Accumulating 
evidences showed modulation of the gut microbiota 
might constitute a potential therapy in children with 
ASD. Correction of Agni and elimination of metabolic 
wastes by Sodhana therapies may prevent intestinal 
inflammatory diseases by regulating intestinal tight 
junction protein expression and barrier function.  
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